Warning: This security is no longer trading.
defunct
Pernix Therapeutics Holdings, Inc. (PTX): Price and Financial Metrics
PTX Price/Volume Stats
| Current price | $0.21 | 52-week high | $3.30 |
| Prev. close | $0.22 | 52-week low | $0.20 |
| Day low | $0.20 | Volume | 1,010,500 |
| Day high | $0.24 | Avg. volume | 2,010,779 |
| 50-day MA | $0.52 | Dividend yield | N/A |
| 200-day MA | $1.23 | Market Cap | 3.05M |
PTX Stock Price Chart Interactive Chart >
Pernix Therapeutics Holdings, Inc. (PTX) Company Bio
Pernix Therapeutics Holdings, Inc. develops, manufactures, markets, and sells branded and generic pharmaceutical products. The companys product include CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product. The company was founded in 1996 and is based in Morristown, New Jersey.
PTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...